These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 24276191)

  • 21. Detection of human papillomavirus-16 in fine-needle aspirates to determine tumor origin in patients with metastatic squamous cell carcinoma of the head and neck.
    Begum S; Gillison ML; Nicol TL; Westra WH
    Clin Cancer Res; 2007 Feb; 13(4):1186-91. PubMed ID: 17317828
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Survey of the use of tests for human papilloma virus and epidermal growth factor receptor for squamous cell carcinoma of the head and neck in UK head and neck multidisciplinary teams.
    Ahmed A; Cascarini L; Sandison A; Clarke P
    Br J Oral Maxillofac Surg; 2012 Mar; 50(2):119-21. PubMed ID: 21450378
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The impact of HPV infection, smoking history, age and operability of the patient on disease-specific survival in a geographically defined cohort of patients with oropharyngeal squamous cell carcinoma.
    Ljøkjel B; Haave H; Lybak S; Aarstad HH; Karlsdottir A; Vintermyr OK; Aarstad HJ
    Acta Otolaryngol; 2014 Sep; 134(9):964-73. PubMed ID: 24963968
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HPV-related Oropharyngeal Carcinoma: A Review of Clinical and Pathologic Features With Emphasis on Updates in Clinical and Pathologic Staging.
    Buckley L; Jackett L; Clark J; Gupta R
    Adv Anat Pathol; 2018 May; 25(3):180-188. PubMed ID: 29394171
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bcl2 and human papilloma virus 16 as predictors of outcome following concurrent chemoradiation for advanced oropharyngeal cancer.
    Nichols AC; Finkelstein DM; Faquin WC; Westra WH; Mroz EA; Kneuertz P; Begum S; Michaud WA; Busse PM; Clark JR; Rocco JW
    Clin Cancer Res; 2010 Apr; 16(7):2138-46. PubMed ID: 20233885
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical features of HPV-related head and neck squamous cell carcinoma: presentation and work-up.
    Koch WM
    Otolaryngol Clin North Am; 2012 Aug; 45(4):779-93. PubMed ID: 22793852
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cancer of unknown primary originating from oropharyngeal carcinomas are strongly correlated to HPV positivity.
    Zengel P; Assmann G; Mollenhauer M; Jung A; Sotlar K; Kirchner T; Ihrler S
    Virchows Arch; 2012 Sep; 461(3):283-90. PubMed ID: 22855133
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of human papillomavirus infection in head and neck cancers.
    Syrjänen S
    Ann Oncol; 2010 Oct; 21 Suppl 7():vii243-5. PubMed ID: 20943622
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human papillomavirus and head and neck cancer.
    Mendenhall WM; Logan HL
    Am J Clin Oncol; 2009 Oct; 32(5):535-9. PubMed ID: 19652580
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human papillomavirus genome detection by in situ hybridization in fine-needle aspirates of metastatic lesions from head and neck squamous cell carcinomas.
    Umudum H; Rezanko T; Dag F; Dogruluk T
    Cancer; 2005 Jun; 105(3):171-7. PubMed ID: 15822131
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular HPV typing as a diagnostic tool to discriminate primary from metastatic squamous cell carcinoma of the lung.
    Weichert W; Schewe C; Denkert C; Morawietz L; Dietel M; Petersen I
    Am J Surg Pathol; 2009 Apr; 33(4):513-20. PubMed ID: 19145203
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human papillomavirus-associated oropharyngeal squamous cell carcinomas: primary tumor burden and survival in surgical patients.
    Ukpo OC; Pritchett CV; Lewis JE; Weaver AL; Smith DI; Moore EJ
    Ann Otol Rhinol Laryngol; 2009 May; 118(5):368-73. PubMed ID: 19548387
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synchronous cancers in patients with head and neck cancer: risks in the era of human papillomavirus-associated oropharyngeal cancer.
    Jain KS; Sikora AG; Baxi SS; Morris LG
    Cancer; 2013 May; 119(10):1832-7. PubMed ID: 23423883
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TP53 gene expression in HPV-positive oral tongue SCC and its correlation with nodal metastasis.
    Seraj JM; Yazdani N; Ashtiani ZO; Seraj SM; Hasheminasab SM; Memar B; Mirashrafi F; Borghei H; Yazdani J; Mostaan LV
    Pathol Res Pract; 2011 Dec; 207(12):758-61. PubMed ID: 22055991
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of cystic neck metastases and human papillomavirus-positive oropharyngeal squamous cell carcinoma.
    McHugh JB
    Arch Pathol Lab Med; 2009 Nov; 133(11):1798-803. PubMed ID: 19886714
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The association between T-stage and clinical nodal metastasis In HPV-positive oropharyngeal cancer.
    Sood AJ; McIlwain W; O'Connell B; Nguyen S; Houlton JJ; Day T
    Am J Otolaryngol; 2014; 35(4):463-8. PubMed ID: 24780201
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An expression profile for diagnosis of lymph node metastases from primary head and neck squamous cell carcinomas.
    Roepman P; Wessels LF; Kettelarij N; Kemmeren P; Miles AJ; Lijnzaad P; Tilanus MG; Koole R; Hordijk GJ; van der Vliet PC; Reinders MJ; Slootweg PJ; Holstege FC
    Nat Genet; 2005 Feb; 37(2):182-6. PubMed ID: 15640797
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HPV and head and neck cancer.
    Dufour X; Beby-Defaux A; Agius G; Lacau St Guily J
    Eur Ann Otorhinolaryngol Head Neck Dis; 2012 Feb; 129(1):26-31. PubMed ID: 21944953
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictors of contralateral-bilateral nodal disease in oropharyngeal cancer: A National Cancer Data Base Study.
    Kato MG; Ellis MA; Nguyen SA; Day TA
    Head Neck; 2018 Feb; 40(2):338-348. PubMed ID: 28963823
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human papillomavirus in head and neck carcinomas: prevalence, physical status and relationship with clinical/pathological parameters.
    Badaracco G; Venuti A; Morello R; Muller A; Marcante ML
    Anticancer Res; 2000; 20(2B):1301-5. PubMed ID: 10810439
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.